Department of Endocrine, Nutrition and Metabolic Diseases

Faculty and Staff

Staff

Patient Care Services

OPD service:

1. Endocrine, Nutrition and Metabolic diseases OPD (every Tuesday & Friday) at Calcutta School of Tropical Medicine.
2. Nutritional counselling, Monitoring and Medical Nutritional Therapy provided all outdoor patients treated in this Department as well as referred from other departments of this institution and other medical institutions.
3. Education and awareness regarding diabetes prevention, malnutrition prevention, living healthy life with diabetes, self-blood glucose monitoring, self-insulin administration techniques etc.
4. Treatment of diabetic complications like neuropathy, CVD, nephropathy, diabetic foot ulcer etc. with special care.

In patient service:

1. Admitting patients to Carmichael Hospital for Tropical Diseases.
2. Visiting referred cases by other departments of Calcutta School of Tropical Medicine.
3. Metabolic, Endocrinological and Nutritional management to patients treated under other departments.

Routine Indoor & OPD Cases

Ongoing Research Activities

1. Correlation of C Peptide level with glycemic control and vascular complications in Type 2 Diabetes Mellitus
2. Effect of Dapagliflozin on arterial stiffness in young patients with Type 2 Diabetes Mellitus
3. Study on assessing Liver fibrosis in Type 2 Diabetic patients
4. Evaluating effects of Low Carbohydrates and High Protein diets in body weight changes and lipid parameters alterations in Type 2 Diabetic patients
5. A Phase III, Randomized, Double Blind, Active-Controlled, Prospective, Comparative, Parallel Group, Multicentric Clinical Study to Evaluate the Efficacy, Safety and Tolerability of Fixed Dose Combination of Empagliflozin, Sitagliptin and Metformin Hydrochloride Extended Release Tablets Versus Fixed Dose Combination of Dapagliflozin, Sitagliptin and Metformin Hydrochloride Extended Release Tablets in Patients with Type 2 Diabetes Mellitus Inadequately Controlled on Metformin Monotherapy.

Publications

1. Naskar A, Mondal A. Factors associated with microalbuminuria in patients with type 2 diabetes: A cross-sectional study from Eastern India. Endocrinol Res Pract. 2024;28(4):224-228.
2. Naskar A, Mondal A, Chatterjee R, De RD, Roy S. Assessing liver fibrosis in type 2 diabetes mellitus patients with metabolic dysfunction-associated steatotic liver disease: The role of non-invasive scoring systems and associated factors. Cureus. 2024;16(6):e62405. doi: 10.7759/cureus.62405.
3. Naskar A, Mondal A, Dhar I. Prevalence of iron deficiency in type 2 diabetes mellitus patients and its association with altered lipid profile. MGM Journal of Medical Sciences. 2024;11(2):228-233. doi: 10.4103/mgmj.mgmj_140_24.
4. Mondal A, Naskar A, Siddiqi SS, Bhosle D. Efficacy and safety of fixed dose combination of sitagliptin, metformin, and pioglitazone in type 2 diabetes (IMPACT study): A randomized controlled trial. Clin Diabetes Endocrinol. 2024;10(3). doi: 10.1186/s40842-023-00161-6.
5. Chatterjee R, Naskar A, Samajdar SS, Mukherjee S, Joshi S, Karmakar PS. Blue Index as a comprehensive, patient-centered assessment of care in diabetic patients. JAPI. 2024;72:0688. doi: 10.59556/japi.72.0688.
6. Singh AK, Sahay R, Gil N, Tripathi S, Khandelwal V, Basu I, Shembalkar J, Srivastava MK, Bhatia G, Pathak V, Dange A, Chaudhri M, Naskar A. A randomized, double-blind, active controlled trial assessing the efficacy and safety of a fixed dose combination (FDC) of metformin hydrochloride 1000 mg ER, sitagliptin phosphate 100 mg, and dapagliflozin propanediol 10 mg in Indian adults with type 2 diabetes: The MESIDA trial. Int J Diabetes Dev Ctries. 2024. doi: 10.1007/s13410-024-01321-9.